Author:
Tozaki Mitsuhiro,Nakamura Seigo
Funder
Ministry of Health, Labour and Welfare
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Radiology, Nuclear Medicine and imaging,Oncology,General Medicine
Reference21 articles.
1. Arai M, Yokoyama S, Watanabe C, Yoshida R, Kita M, Okawa M, et al. Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan. J Hum Genet. 2018;63:447–57.
2. Guidelines for the optimal use of breast MRI for screening of breast cancer in high-risk women, the Japan Association of Breast Cancer Screening. https://www.jabcs.jp/images/mri_guideline_fix.pdf. Accessed 3 July 2020.
3. Taira N, Arai M, Ikeda M, Iwasaki M, Okamura H, Takamatsu K, et al. The Japanese Breast Cancer Society clinical practice guideline for epidemiology and prevention of breast cancer. Breast Cancer. 2015;22:16–27.
4. Taira N, Arai M, Ikeda M, Iwasaki M, Okamura H, Takamatsu K, et al. The Japanese Breast Cancer Society clinical practice guidelines for epidemiology and prevention of breast cancer, 2015 edition. Breast Cancer. 2016;23:343–56.
5. Guidebook for diagnosis and treatment of Hereditary Breast and Ovarian Cancer Syndrome 2017, Kanehara shuppan 2017.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献